"Enzon Pharmaceuticals, Inc. is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value."
You have two recent posts on ENZN and you've been on Ihub since 2016. I'm really curious how you found this one. It has quite a long history with Icahn.